1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
a cliff after a disappointing quarterly update that missed consensus top-line estimates. The healthcare giant is roughly 22% down from its 52-week high of $139.06 as of writing. However, for investors focused on the long game, this may be a great opportunity to load up on the stock. Read on to find out why. Multiple growth avenues and an attractive dividend Abbott Laboratories' revenue in the fourth quarter increased by just 4.4% year over year to $11.5 billion. Weak performances within the company's diagnostic and nutrition businesses pulled sales growth in the wrong direction. Can Abbott Laboratories jump-start revenue growth? My view is that it can. Let's consider three reasons why. First, the company's most important segment, medical devices , continues to perform well. In the fourth quarter, Abbott's medical device revenue of $5.7 billion increased by 12.3% year over year. Will AI create the world's first trillionaire? Our team just released a report on the one little-known
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design [Yahoo! Finance]Yahoo! Finance
- Abbott Diabetes And Cardiology Updates Test Growth Story For Investors [Yahoo! Finance]Yahoo! Finance
- This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Unveils XIENCE Skypoint to Advance Cardiovascular Treatment in India [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website